The invention relates to compounds of formula (I): n n n n n n n n n n or a salt thereof, wherein R 1 , A, L, and R 2 and n are as described herein. Compounds of formula (I) and pharmaceutical compositions thereof are αvβ1 integrin inhibitors that are useful for treating tissue specific fibrosis.